US20100310713A1 - Probiotic composition - Google Patents
Probiotic composition Download PDFInfo
- Publication number
- US20100310713A1 US20100310713A1 US12/679,171 US67917108A US2010310713A1 US 20100310713 A1 US20100310713 A1 US 20100310713A1 US 67917108 A US67917108 A US 67917108A US 2010310713 A1 US2010310713 A1 US 2010310713A1
- Authority
- US
- United States
- Prior art keywords
- probiotic
- lactobacillus
- cfu
- gum arabic
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000006041 probiotic Substances 0.000 title claims abstract description 138
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 138
- 230000000529 probiotic effect Effects 0.000 title claims abstract description 137
- 239000000203 mixture Substances 0.000 title claims abstract description 49
- 235000013305 food Nutrition 0.000 claims abstract description 42
- 235000013361 beverage Nutrition 0.000 claims abstract description 40
- 238000004519 manufacturing process Methods 0.000 claims abstract description 14
- 244000215068 Acacia senegal Species 0.000 claims description 66
- 229920000084 Gum arabic Polymers 0.000 claims description 64
- 235000010489 acacia gum Nutrition 0.000 claims description 64
- 239000000205 acacia gum Substances 0.000 claims description 64
- 235000013399 edible fruits Nutrition 0.000 claims description 46
- 235000015203 fruit juice Nutrition 0.000 claims description 29
- 235000013365 dairy product Nutrition 0.000 claims description 25
- 235000019543 dairy drink Nutrition 0.000 claims description 24
- 239000000243 solution Substances 0.000 claims description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 241000186660 Lactobacillus Species 0.000 claims description 6
- 241000186605 Lactobacillus paracasei Species 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 241000186000 Bifidobacterium Species 0.000 claims description 4
- 229940039696 lactobacillus Drugs 0.000 claims description 4
- 241000186018 Bifidobacterium adolescentis Species 0.000 claims description 3
- 241001134770 Bifidobacterium animalis Species 0.000 claims description 3
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims description 3
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 3
- 241000186012 Bifidobacterium breve Species 0.000 claims description 3
- 241001608472 Bifidobacterium longum Species 0.000 claims description 3
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 claims description 3
- 241000194032 Enterococcus faecalis Species 0.000 claims description 3
- 241000194031 Enterococcus faecium Species 0.000 claims description 3
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 3
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 3
- 241000186713 Lactobacillus amylovorus Species 0.000 claims description 3
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims description 3
- 244000199866 Lactobacillus casei Species 0.000 claims description 3
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 3
- 241000218492 Lactobacillus crispatus Species 0.000 claims description 3
- 241001147746 Lactobacillus delbrueckii subsp. lactis Species 0.000 claims description 3
- 241000186840 Lactobacillus fermentum Species 0.000 claims description 3
- 241001468157 Lactobacillus johnsonii Species 0.000 claims description 3
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 3
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 3
- 241000186604 Lactobacillus reuteri Species 0.000 claims description 3
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 3
- 241000186869 Lactobacillus salivarius Species 0.000 claims description 3
- 241000191998 Pediococcus acidilactici Species 0.000 claims description 3
- 241000194020 Streptococcus thermophilus Species 0.000 claims description 3
- 229940118852 bifidobacterium animalis Drugs 0.000 claims description 3
- 229940002008 bifidobacterium bifidum Drugs 0.000 claims description 3
- 229940004120 bifidobacterium infantis Drugs 0.000 claims description 3
- 229940009289 bifidobacterium lactis Drugs 0.000 claims description 3
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 3
- 229940032049 enterococcus faecalis Drugs 0.000 claims description 3
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 3
- 229940017800 lactobacillus casei Drugs 0.000 claims description 3
- 229940012969 lactobacillus fermentum Drugs 0.000 claims description 3
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 3
- 229940001882 lactobacillus reuteri Drugs 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 229960002181 saccharomyces boulardii Drugs 0.000 claims description 3
- 241000186606 Lactobacillus gasseri Species 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 241000186672 Lactobacillus delbrueckii subsp. bulgaricus Species 0.000 claims 1
- 235000015205 orange juice Nutrition 0.000 description 88
- 238000011282 treatment Methods 0.000 description 75
- 239000000047 product Substances 0.000 description 54
- 230000004083 survival effect Effects 0.000 description 30
- 210000004027 cell Anatomy 0.000 description 28
- 235000015197 apple juice Nutrition 0.000 description 27
- 239000002609 medium Substances 0.000 description 21
- 230000035899 viability Effects 0.000 description 20
- 239000000843 powder Substances 0.000 description 19
- 238000003860 storage Methods 0.000 description 19
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 18
- 238000011081 inoculation Methods 0.000 description 14
- 238000007792 addition Methods 0.000 description 12
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 description 11
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 description 11
- 235000004634 cranberry Nutrition 0.000 description 11
- 230000004224 protection Effects 0.000 description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 240000001717 Vaccinium macrocarpon Species 0.000 description 8
- 230000008859 change Effects 0.000 description 8
- 230000007423 decrease Effects 0.000 description 8
- 230000003833 cell viability Effects 0.000 description 7
- 150000007524 organic acids Chemical class 0.000 description 7
- 235000010633 broth Nutrition 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 150000008163 sugars Chemical class 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 230000030833 cell death Effects 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 239000000416 hydrocolloid Substances 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 244000291414 Vaccinium oxycoccus Species 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 229940093915 gynecological organic acid Drugs 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 239000002054 inoculum Substances 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 238000007747 plating Methods 0.000 description 3
- 230000009979 protective mechanism Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- QIJRTFXNRTXDIP-UHFFFAOYSA-N (1-carboxy-2-sulfanylethyl)azanium;chloride;hydrate Chemical compound O.Cl.SCC(N)C(O)=O QIJRTFXNRTXDIP-UHFFFAOYSA-N 0.000 description 2
- XMTQQYYKAHVGBJ-UHFFFAOYSA-N 3-(3,4-DICHLOROPHENYL)-1,1-DIMETHYLUREA Chemical compound CN(C)C(=O)NC1=CC=C(Cl)C(Cl)=C1 XMTQQYYKAHVGBJ-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 241000483634 Bifidobacterium animalis subsp. lactis BB-12 Species 0.000 description 2
- 238000009631 Broth culture Methods 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000000692 Student's t-test Methods 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 230000001332 colony forming effect Effects 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 229960001305 cysteine hydrochloride Drugs 0.000 description 2
- 239000005293 duran Substances 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000006872 mrs medium Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000013207 serial dilution Methods 0.000 description 2
- 238000010972 statistical evaluation Methods 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- 235000008924 yoghurt drink Nutrition 0.000 description 2
- 235000013618 yogurt Nutrition 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- 239000001904 Arabinogalactan Substances 0.000 description 1
- 229920000189 Arabinogalactan Polymers 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- -1 KCl) Chemical class 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 108010084695 Pea Proteins Proteins 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 235000019312 arabinogalactan Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000006727 cell loss Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020351 fruit smoothie Nutrition 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960002743 glutamine Drugs 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 235000014705 isoleucine Nutrition 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000001139 pH measurement Methods 0.000 description 1
- 238000009928 pasteurization Methods 0.000 description 1
- 235000019702 pea protein Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 108020001775 protein parts Proteins 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/25—Exudates, e.g. gum arabic, gum acacia, gum karaya or tragacanth
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/165—Paracasei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/515—Animalis
Definitions
- the present invention relates to a probiotic composition
- a probiotic composition comprising a probiotic culture having a probiotic count of between 10 6 and 10 10 cfu/ml or cfu/g and a carrier medium.
- the invention also relates to a process for preparing the probiotic composition and to probiotic beverage and food products comprising the probiotic composition.
- probiotic culture refers to a population of live microorganisms which beneficially affect a host by improving its intestinal microbial balance.
- by weight refers to the weight of the probiotic composition unless otherwise specified.
- Probiotic compositions comprising probiotic cultures are well known and include food and beverage products such as probiotic yoghurts and yoghurt drinks.
- the probiotic culture at the time of consumption should have a probiotic count of at least 10 6 cfu/ml or cfu/g, and preferably between 10 7 and 10 9 cfu/ml or cfu/g.
- the specific probiotic requirements are also dependent on the type of probiotic culture. If the probiotic viability of the product is reduced, then the product cannot claim to have probiotic capability.
- probiotic products however are the survival of the cultures over the shelf life of the product.
- the product In order to ensure that there is sufficient probiotic viability in a product, the product must be of a certain type or must be kept under certain conditions to guarantee a high survival rate of the culture.
- Probiotic bacteria are sensitive to many environmental factors such as pH, temperature, moisture, air (oxygen), and light, and this limits the type of food and beverage products which can be used to carry the probiotic cultures.
- probiotic composition which can maintain viability under a wider range of conditions and a process for preparing such a probiotic composition.
- a probiotic food and beverage product which has an extended shelf life and maintains probiotic capability during its shelf life.
- a probiotic composition comprising a probiotic culture having a probiotic count of between 10 6 and 10 10 cfu/ml or cfu/g and a carrier medium;
- the addition of gum Arabic to the probiotic composition provides protection for the probiotic culture. This has been found to increase both the survival rate and viability of the probiotic culture either within the composition or after being added to a food or beverage product thus resulting in an extended shelf life for the product. Additionally, due to the increased viability of the culture, it has been found that the inoculum level of the culture can be decreased during manufacture of the product. This will still result in a viable count of probiotic culture, and will also lead to associated cost advantages. As the probiotic culture has increased stability in the products the manufacturing step of forming an encapsulated probiotic culture using spray or freeze-drying can generally be obviated thus resulting in further associated cost advantages.
- gum Arabic has the ability to attach itself more easily to microorganisms. This is thought to be due to a protein part within the gum Arabic structure which most other hydrocolloids do not have and which results in the gum Arabic having higher surface activity than other hydrocolloids. Additionally, the structure of gum arabic is more compact compared with other hydrocolloids. Thus, from an energy point of view it will cost less for the gum arabic molecule to attach itself and remain attached to the surface of the microorganism.
- the gum arabic When attached to the probiotic microorganisms, the gum arabic can act as a barrier and can prevent the diffusion of certain compounds into the cells of the microorganisms. This allows the probiotic cultures to remain viable under low pHs. It has also been found that the gum Arabic can change the chemistry of the organic acids
- the gum Arabic has a viscosity in the region of between 20 and 200 cP at 25% (w/w) solution and 25° C. in an aqueous solution as measured at a shear rate of between 0.1 s ⁇ 1 and 1000 s ⁇ 1 .
- the carrier medium is selected from the group comprising one or more of MRS broth, mMRS solution, and water and the gum Arabic is in the amount of between 30% and 99% by weight.
- the probiotic composition is suitable for addition to a beverage or food product having a pH of 4 or less than 4 in an amount sufficient to provide between 0.1% and 10% gum Arabic by weight of the product.
- the probiotic composition is suitable for addition to a beverage or food product in an amount sufficient to provide between 0.5% and 5% gum Arabic by weight.
- the carrier medium is a beverage or food product having a pH of 4 or less than 4 and the gum Arabic is in the amount of between 0.1 and 10% by weight.
- the gum Arabic is in the amount of between 0.5 and 5% by weight.
- the increased stability of the cultures enables them to be included in foods which are not generally suitable for probiotic cultures.
- the probiotic cultures contained within the probiotic composition of the present invention remain stable under low pHs and in particular pHs of 4 or less than 4.
- the probiotic composition of the invention has extended the range of food or beverage products which can be inoculated with probiotic cultures.
- the probiotic culture has a probiotic count of between 10 7 and 10 9 cfu/ml or cfu/g.
- the probiotic culture is selected from the group comprising one or more of Bifidobacterium animalis, Bifidobacterium adolescentis, Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium essensis, Bifidobacterium infantis, Bifidobacterium lactis, Bifidobacterium longum, Lactobacillus paracasei, Lactobacillus acidophilus, Lactobacillus delbrueckii subsp.
- Lactobacillus casei Lactobacillus crispatus
- Lactobacillus johnsonii Lactobacillus lactis, Lactobacillus fermentum, Lactobacillus plantarum, Lactobacillus rhamnosus, Lactobacillus reuteri, Lactobacillus salivarius, Lactobacillus amylovorus, Lactobacillus gasseri, Lactobacillus pentosaceus, Enterococcus faecalis, Enterococcus faecium, Pediococcus acidilactici, Propioniobacterium freundenreichii, Saccharomyces boulardii and Streptococcus thermophilus.
- the probiotic composition further comprises one or more of buffers, salts, sugars, polysaccharides and proteins.
- probiotic beverage or food product comprising the probiotic composition of the invention.
- the probiotic beverage or food product has a pH of 4 or less than 4.
- the probiotic beverage or food product is selected from the group comprising one or more of fruit juices, fruit drinks, fruit juice, fruit drink or fruit containing products such as mixed fruit juice/dairy drinks, mixed fruit juice/non-dairy drinks, mixed fruit juice/dairy food products, mixed fruit juice/non-dairy food products, mixed fruit drink/dairy drinks, mixed fruit drink/non-dairy drinks, mixed fruit drink/dairy food products, mixed fruit drink/non-dairy food products, mixed fruit/dairy drinks, mixed fruit/non-dairy drinks, mixed fruit/dairy food products, mixed fruit/non-dairy food products.
- a process for preparing a probiotic composition comprising a probiotic culture having a probiotic count of between 10 6 and 10 10 cfu/ml or cfu/g and a carrier medium, the process comprising:
- the probiotic culture comprises harvested cells having a probiotic count of between 10 6 and 10 10 cfu/ml or cfu/g and the harvested cells are resuspended in the gum Arabic solution.
- the probiotic culture comprises a starter culture; and wherein the culture is grown in the gum Arabic solution to provide a probiotic count of between 10 6 and 10 10 cfu/ml or cfu/g.
- the carrier medium is selected from the group comprising one or more of MRS broth, mMRS solution, and water.
- the probiotic composition is subsequently added to a food or beverage product having a pH of 4 or less than 4.
- the carrier medium is a beverage or food product having a pH of 4 or less than 4.
- gum Arabic to improve the viability of a probiotic culture in a composition having a pH of 4 or less than 4.
- FIG. 1 depicts mean log cfu/ml of orange juice inoculated with Bb12 and stored at 4° C.
- FIG. 2 depicts pH of orange juice inoculated with Bb12 and stored at 4° C.
- FIG. 3 depicts mean log cfu/ml of orange juice inoculated with Bb12 and stored at 15° C.
- FIG. 4 depicts pH of orange juice inoculated with Bb12 and stored at 15° C.
- FIG. 5 depicts mean log cfu/ml of orange juice inoculated with 338 and stored at 4° C.
- FIG. 6 depicts pH of orange juice inoculated with 338 and stored at 4° C.
- FIG. 7 depicts mean log cfu/ml of orange juice inoculated with 338 and stored at 15° C.
- FIG. 8 depicts pH of orange juice inoculated with 338 and stored at 15° C.
- FIGS. 9 to 13 depict mean log cfu/ml ( ⁇ SD) of Bb12 in orange juice with and without varying concentrations of EmulGold
- FIGS. 14 to 18 depict pH ( ⁇ SD) of orange juice inoculated with Bb12 with and without varying concentrations of EmulGold.
- FIGS. 19 to 24 depict mean log cfu/ml of Bb12 ( ⁇ SD) in orange juice with and without 3% w/v EmulGold and varying inoculation levels of Bb12.
- FIGS. 25 to 30 depict pH ( ⁇ SD) of orange juice with and without 3% w/v EmulGold, inoculated with varying levels of Bb12.
- FIG. 31 depicts log cfu/ml ( ⁇ SD) of Bb12 in apple juice with and without 1.3% w/v EmulGold.
- FIG. 32 depicts pH ( ⁇ SD) of apple juice inoculated with Bb12 with and without 1.3% w/v EmulGold.
- FIG. 33 depicts mean log cfu/ml ( ⁇ SD) of Bb12 in cranberry juice with and without 1.3% w/v EmulGold.
- FIG. 34 depicts pH ( ⁇ SD) of cranberry juice inoculated with Bb12 with and without EmulGold.
- FIG. 35 depicts mean log cfu/ml ( ⁇ SD) of Bb12 in orange juice, apple juice and cranberry juice.
- FIG. 36 depicts pH ( ⁇ SD) of orange juice, apple juice and cranberry juice.
- the probiotic composition of the present invention is prepared by dissolving gum Arabic in a carrier medium to provide a gum Arabic solution. Probiotic culture is then added to the gum Arabic solution to provide the probiotic composition.
- Gum Arabic is a highly branched arabinogalactan and is generally available in the form of a powder and requires dissolution in the carrier medium prior to addition of the probiotic culture. Gum Arabic is also available in agglomerated or already dissolved forms. Gum Arabic can be selected from either Acacia Senegal or Acacia Seyal . Both types of gum Arabic have similar properties although there are slight differences in their sugar composition and molar mass.
- the probiotic culture can either comprise harvested cells or a starter culture.
- the harvested cells can be prepared by routine culturing in a standard medium which can optionally be substituted with further nutrients.
- the cells are generally harvested by centrifugation and washed using a standard diluent such as Maximum Recovery Diluent (MRD).
- MRD Maximum Recovery Diluent
- the cells can then be resuspended in MRD or other suitable type of diluent or medium.
- the gum Arabic solution is then inoculated with the cells so as to provide between 10 6 and 10 10 cfu/ml or cfu/g of probiotic culture per ml of gum Arabic solution and preferably between 10 7 and 10 9 cfu/ml or cfu/g.
- the probiotic culture is a starter culture this culture is then grown in the gum Arabic solution to provide a probiotic count in this range.
- the probiotic culture could be any of Bifidobacterium animalis, Bifidobacterium adolescentis, Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium essensis, Bifidobacterium infantis, Bifidobacterium lactis, Bifidobacterium longum, Lactobacillus paracasei, Lactobacillus acidophilus, Lactobacillus delbrueckii subsp.
- the carrier medium used to dissolve the gum Arabic can be any type of food grade nutrient medium in the form of a liquid, aqueous based solution, semi-liquid or semi-solid which would allow dissolution of the gum Arabic.
- nutrient media include MRS broth, mMRS solution or water.
- the probiotic composition has been found to be particularly useful in preparing acidic probiotic beverage and food products and in particular probiotic beverage or food products having a pH of 4 or less than 4.
- the carrier medium can itself be a beverage or food product.
- This beverage or food product can either be an acidic beverage or food product or can subsequently be added to an acidic beverage or food product as outlined above.
- suitable products have a pH of 4 or less than 4 and include fruit juices, fruit drinks, fruit juice containing products, fruit drink containing products or fruit containing products such as mixed fruit juice/dairy drinks, mixed fruit juice/non-dairy drinks, mixed fruit juice/dairy food products, mixed fruit juice/non-dairy food products, mixed fruit drink/dairy drinks, mixed fruit drink/non-dairy drinks, mixed fruit drink/dairy food products, mixed fruit drink/non-dairy food products, mixed fruit/dairy drinks, mixed fruit/non-dairy drinks, mixed fruit/non-dairy drinks, mixed fruit/dairy food products, mixed fruit/dairy drinks, mixed fruit/non-dairy drinks, mixed fruit/dairy food products, mixed fruit/non-dairy
- beverage and food products would also include products such as fruit yoghurts and fruit yoghurt drinks, fruit smoothies, and any type of berry containing beverage or food product.
- the carrier medium is a nutrient medium and the resultant probiotic composition is then added to a beverage or food product to provide a probiotic product.
- This product should generally have in the region of between 0.1% and 10%, and preferably between 0.5% and 5% gum Arabic by weight of the product. If the probiotic composition is being added to a beverage or food product it can generally be added at any stage during production and preferably after any heating or pasteurisation treatment.
- the carrier medium is a beverage or food product
- the gum Arabic can be dissolved in this beverage or food product to provide the gum Arabic solution and the probiotic culture can either be resuspended or grown in this solution.
- buffer such as buffer, salts, sugars, polysaccharides, amino acids, proteins and vitamins
- RDI recommended daily intake
- An example of a buffer which could be added includes sodium citrate or citric acid.
- the salts added could be any of sodium salts (e.g NaCl), potassium salts (e.g. KCl), or magnesium salts (e.g. MgCl 2 ).
- sugars could be dextrose, sucrose, fructose and inverted sugars.
- polysaccharides could be carrageenan, pectin, alginate, guar gum, carboxymethylcellulose, locust bean gum and xanthan gum. Any type of essential amino acid could be added such as isoleucine, glutamine, alanine, and cysteine.
- Suitable proteins would include any type of plant based or dairy based proteins, such as whey, casein, pea protein, wheat-protein and soy protein.
- vitamins would be Vitamin A, Thiamin (Vitamin B1), Riboflavin (Vitamin B2) and ascorbic acid (Vitamin C).
- treatments 1-3 Three probiotic compositions were prepared according to the invention, (treatments 1-3). A standard of orange juice comprising probiotic culture was also prepared, (treatment 4).
- EmulGoldTM powder which is made from the species Acacia senegal was supplied in a screw-cap container with a total weight of approximately 1.5 kg. Both were stored at room temperature. EmulGoldTM powder was added to OJ, mixed by hand and left at room temperature for 60 min before being stored at 4° C. Similarly powder was added to mMRS prior to inoculation with the probiotic cultures. No growth was noted in the GA+mMRS solution alone after 2 days incubation under anaerobic conditions at 37° C.
- Lactobacillus paracasei NFBC 338 and Bifidobacterium animalis subsp. lactis Bb12 were both routinely cultured in Lactobacilli MRS medium (Difco, USA) supplemented with 0.05% (w/v) cysteine-hydrochloride (mMRS) and grown at 37° C. in an anaerobic work chamber (Ruskin in vivo 400, set at 8% hydrogen, 8% carbon dioxide and 84% nitrogen). Colonies of each strain were cultured on mMRS agar and were used to inoculate 10 ml mMRS broths.
- mMRS cysteine-hydrochloride
- Treatment 1 the probiotic cultures were grown in the presence of 3% (w/v) GA prior to their addition to the OJ samples.
- the cfu/ml was determined for a 1 ml sample of OJ following serial dilution in MRD and pour plating with mMRS. Colonies were counted after 3 days incubation. Each OJ sample was tested twice and a mean cfu/ml value calculated following sampling at 0, 7, 14, 21 and 28 days for strain 338 and 0, 6, 13, 19/20 and 27 days for strain Bb12. All statistical evaluations were based on the Student's t-Test (2-tail paired) and significances were measured at a probability level p ⁇ 0.01.
- the pH of the OJ samples was determined using a Mettler Toledo pH meter calibrated prior to each series of measurements. At each time point ⁇ 5 ml of OJ was taken and allowed to reach room temperature before a pH reading was taken.
- EmulGoldTM in the form of powder was supplied and stored at room temperature.
- the powder was added directly to a number of samples based on a specified w/v concentration and mixed on a shaking platform for 30 min at room temperature. In all cases, the powder was added to ⁇ 80 ml of juice and brought up to 100 ml following complete dissolution.
- B. animatis subsp. lactis Bb12 was routinely cultured in Lactobacilli MRS medium (Difco, USA) supplemented with 0.05% (w/v) cysteine-hydrochloride (mMRS) and grown at 37° C. in an anaerobic work chamber (Ruskin in vivo 400, set at 8% hydrogen, 8% carbon dioxide and 84% nitrogen). Colonies were cultured on mMRS agar. For each batch of cells cultured prior to sample inoculation the following procedure was followed. Colonies were added to 10 ml mMRS broth and incubated for ⁇ 24 hours.
- Lactobacilli MRS medium Daifco, USA
- mMRS cysteine-hydrochloride
- a second broth culture was initiated and incubated for ⁇ 20 hours or until the medium pH reached ⁇ 4.2.
- a third broth culture was established using the same parameters and was found to yield ⁇ 2 ⁇ 10 9 cfu/ml. Based on this cell density a final volume was calculated depending on the required cfu/ml of fruit juice and the number of treatments. Cells were harvested by centrifugation washed twice in sterile water and re-suspended in sterile water from which 1 ml was used to inoculate 100 ml samples. This was estimated to yield ⁇ 2 ⁇ 10 7 cfu of probiotic per ml of sample. For other inoculation levels the culture was concentrated or further diluted to provide a constant 1 ml inoculation.
- the pH of all samples was determined using a Mettler Toledo pH meter calibrated prior to each series of measurements. Following the removal of 1 ml for cfu/ml analysis samples were allowed to reach room temperature before a pH measurement was taken.
- a storage index (SI) was established based on the number of days required to yield a 0.5 log reduction in cell density from that measured on the first day of sampling.
- SI storage index
- the percent survival at the last day of storage was compared. This was determined by dividing the cfu/ml on the last day by the cfu/ml of the first sample ⁇ 100.
- Example 2 The comparable control and 3% treatment in Example 2 yielded similar results.
- the control SI and percent survival were 49 and 51 days and 0.7 and 1.2%, respectively.
- the SI values were 57 and 59 days, ⁇ SI+8 and +8, percent survival 9.8 and 11%, and fold increase in survival 14 and 9.
- the results for cell stability are shown in FIGS. 19 to 24 .
- Red coloured juices are known to contain specific antimicrobial component, such as, polyphenols and may play a role and provide an alternative cause of cell death. This could explain why no increase was observed in the SD of EmulGold treatments compared with the control.
- the results for cell viability are shown in FIGS. 33 and 35 .
- EmulGold effectively protects Bb12 in OJ stored for over 40 days at 4° C. There was some indication that the lower inoculation levels were more effectively protected based on their fold increase in survival. Similarly there was evidence that EmulGold protected better at 5% w/v compared to lower concentrations.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Dispersion Chemistry (AREA)
- Mycology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Jellies, Jams, And Syrups (AREA)
Abstract
A probiotic composition comprising a probiotic culture having a probiotic count of between 106 and 1010 cfu/ml or cfu/g and a carrier medium is disclosed. The invention also relates to a process for preparing the probiotic composition and to probiotic beverage and food products comprising the probiotic composition.
Description
- The present invention relates to a probiotic composition comprising a probiotic culture having a probiotic count of between 106 and 1010 cfu/ml or cfu/g and a carrier medium. The invention also relates to a process for preparing the probiotic composition and to probiotic beverage and food products comprising the probiotic composition.
- In the specification, the term “probiotic culture” refers to a population of live microorganisms which beneficially affect a host by improving its intestinal microbial balance. In the specification the term “by weight” refers to the weight of the probiotic composition unless otherwise specified.
- Probiotic compositions comprising probiotic cultures are well known and include food and beverage products such as probiotic yoghurts and yoghurt drinks. Generally, in order for a product to be considered probiotic, the probiotic culture at the time of consumption should have a probiotic count of at least 106 cfu/ml or cfu/g, and preferably between 107 and 109 cfu/ml or cfu/g. The specific probiotic requirements are also dependent on the type of probiotic culture. If the probiotic viability of the product is reduced, then the product cannot claim to have probiotic capability.
- The main problem with probiotic products however is the survival of the cultures over the shelf life of the product. Presently, in order to ensure that there is sufficient probiotic viability in a product, the product must be of a certain type or must be kept under certain conditions to guarantee a high survival rate of the culture. Probiotic bacteria are sensitive to many environmental factors such as pH, temperature, moisture, air (oxygen), and light, and this limits the type of food and beverage products which can be used to carry the probiotic cultures.
- In the case of pH, most probiotic cultures will only remain viable in products having a pH of between 4.5 and 8, and thus the type of food and beverage products suitable for conversion into probiotic products is limited. Additionally, the recommended shelf-life of that product may need to be reduced to take into account the presence of the probiotics, thus having cost implications for manufacturers.
- Furthermore, even for any food or beverage products which can maintain probiotic cultures, certain specific manufacturing steps must be carried out in order to protect the cultures. These manufacturing processes include encapsulation and freeze drying of the culture and lead to an increase in the cost of manufacture of the product as well as lengthening the manufacturing process.
- Thus there is a need for a probiotic composition which can maintain viability under a wider range of conditions and a process for preparing such a probiotic composition. There is further a need for a probiotic food and beverage product which has an extended shelf life and maintains probiotic capability during its shelf life.
- According to the invention, there is provided a probiotic composition comprising a probiotic culture having a probiotic count of between 106 and 1010 cfu/ml or cfu/g and a carrier medium;
-
- characterised in that:
- the probiotic composition further comprises between 0.1% and 99.9% gum Arabic by weight.
- It has surprisingly been found that the addition of gum Arabic to the probiotic composition provides protection for the probiotic culture. This has been found to increase both the survival rate and viability of the probiotic culture either within the composition or after being added to a food or beverage product thus resulting in an extended shelf life for the product. Additionally, due to the increased viability of the culture, it has been found that the inoculum level of the culture can be decreased during manufacture of the product. This will still result in a viable count of probiotic culture, and will also lead to associated cost advantages. As the probiotic culture has increased stability in the products the manufacturing step of forming an encapsulated probiotic culture using spray or freeze-drying can generally be obviated thus resulting in further associated cost advantages.
- It has also been found that in comparison with other hydrocolloids, gum Arabic has the ability to attach itself more easily to microorganisms. This is thought to be due to a protein part within the gum Arabic structure which most other hydrocolloids do not have and which results in the gum Arabic having higher surface activity than other hydrocolloids. Additionally, the structure of gum arabic is more compact compared with other hydrocolloids. Thus, from an energy point of view it will cost less for the gum arabic molecule to attach itself and remain attached to the surface of the microorganism.
- When attached to the probiotic microorganisms, the gum arabic can act as a barrier and can prevent the diffusion of certain compounds into the cells of the microorganisms. This allows the probiotic cultures to remain viable under low pHs. It has also been found that the gum Arabic can change the chemistry of the organic acids
- In one embodiment of the invention, the gum Arabic has a viscosity in the region of between 20 and 200 cP at 25% (w/w) solution and 25° C. in an aqueous solution as measured at a shear rate of between 0.1 s−1 and 1000 s−1.
- In one embodiment of the invention, the carrier medium is selected from the group comprising one or more of MRS broth, mMRS solution, and water and the gum Arabic is in the amount of between 30% and 99% by weight.
- In this embodiment of the invention, the probiotic composition is suitable for addition to a beverage or food product having a pH of 4 or less than 4 in an amount sufficient to provide between 0.1% and 10% gum Arabic by weight of the product.
- In this embodiment of the invention, the probiotic composition is suitable for addition to a beverage or food product in an amount sufficient to provide between 0.5% and 5% gum Arabic by weight.
- In another embodiment of the invention, the carrier medium is a beverage or food product having a pH of 4 or less than 4 and the gum Arabic is in the amount of between 0.1 and 10% by weight.
- In this embodiment of the invention, the gum Arabic is in the amount of between 0.5 and 5% by weight.
- The increased stability of the cultures enables them to be included in foods which are not generally suitable for probiotic cultures. In particular it has been found that the probiotic cultures contained within the probiotic composition of the present invention remain stable under low pHs and in particular pHs of 4 or less than 4. Thus the probiotic composition of the invention has extended the range of food or beverage products which can be inoculated with probiotic cultures.
- Ideally, wherein the probiotic culture has a probiotic count of between 107 and 109 cfu/ml or cfu/g.
- Preferably, the probiotic culture is selected from the group comprising one or more of Bifidobacterium animalis, Bifidobacterium adolescentis, Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium essensis, Bifidobacterium infantis, Bifidobacterium lactis, Bifidobacterium longum, Lactobacillus paracasei, Lactobacillus acidophilus, Lactobacillus delbrueckii subsp. bulgaricus, Lactobacillus casei, Lactobacillus crispatus, Lactobacillus johnsonii, Lactobacillus lactis, Lactobacillus fermentum, Lactobacillus plantarum, Lactobacillus rhamnosus, Lactobacillus reuteri, Lactobacillus salivarius, Lactobacillus amylovorus, Lactobacillus gasseri, Lactobacillus pentosaceus, Enterococcus faecalis, Enterococcus faecium, Pediococcus acidilactici, Propioniobacterium freundenreichii, Saccharomyces boulardii and Streptococcus thermophilus.
- In another embodiment of the invention, the probiotic composition further comprises one or more of buffers, salts, sugars, polysaccharides and proteins.
- According to the invention, there is also provided a probiotic beverage or food product comprising the probiotic composition of the invention.
- In one embodiment of the invention, the probiotic beverage or food product has a pH of 4 or less than 4.
- In another embodiment of the invention, the probiotic beverage or food product is selected from the group comprising one or more of fruit juices, fruit drinks, fruit juice, fruit drink or fruit containing products such as mixed fruit juice/dairy drinks, mixed fruit juice/non-dairy drinks, mixed fruit juice/dairy food products, mixed fruit juice/non-dairy food products, mixed fruit drink/dairy drinks, mixed fruit drink/non-dairy drinks, mixed fruit drink/dairy food products, mixed fruit drink/non-dairy food products, mixed fruit/dairy drinks, mixed fruit/non-dairy drinks, mixed fruit/dairy food products, mixed fruit/non-dairy food products.
- According to the invention, there is further provided a process for preparing a probiotic composition comprising a probiotic culture having a probiotic count of between 106 and 1010 cfu/ml or cfu/g and a carrier medium, the process comprising:
-
- dissolving between 0.1% and 99.9% gum Arabic by weight in the carrier medium to provide a gum Arabic solution; and
- adding the probiotic culture to the gum Arabic solution to provide the probiotic composition.
- In one embodiment of the invention, the probiotic culture comprises harvested cells having a probiotic count of between 106 and 1010 cfu/ml or cfu/g and the harvested cells are resuspended in the gum Arabic solution.
- In another embodiment of the invention, the probiotic culture comprises a starter culture; and wherein the culture is grown in the gum Arabic solution to provide a probiotic count of between 106 and 1010 cfu/ml or cfu/g.
- In a further embodiment of the invention, the carrier medium is selected from the group comprising one or more of MRS broth, mMRS solution, and water.
- In this embodiment of the invention, the probiotic composition is subsequently added to a food or beverage product having a pH of 4 or less than 4.
- In a still further embodiment of the invention, the carrier medium is a beverage or food product having a pH of 4 or less than 4.
- According to the invention, there is still further provided the use of gum Arabic to improve the viability of a probiotic culture in a composition having a pH of 4 or less than 4.
- The invention will now be more clearly understood from the following description of some embodiments thereof given by way of example only with reference to the accompanying drawings, in which:
-
FIG. 1 depicts mean log cfu/ml of orange juice inoculated with Bb12 and stored at 4° C.; -
FIG. 2 depicts pH of orange juice inoculated with Bb12 and stored at 4° C.; -
FIG. 3 depicts mean log cfu/ml of orange juice inoculated with Bb12 and stored at 15° C.; -
FIG. 4 depicts pH of orange juice inoculated with Bb12 and stored at 15° C.; -
FIG. 5 depicts mean log cfu/ml of orange juice inoculated with 338 and stored at 4° C.; -
FIG. 6 depicts pH of orange juice inoculated with 338 and stored at 4° C.; -
FIG. 7 depicts mean log cfu/ml of orange juice inoculated with 338 and stored at 15° C.; and -
FIG. 8 depicts pH of orange juice inoculated with 338 and stored at 15° C. -
FIGS. 9 to 13 depict mean log cfu/ml (±SD) of Bb12 in orange juice with and without varying concentrations of EmulGold -
FIGS. 14 to 18 depict pH (±SD) of orange juice inoculated with Bb12 with and without varying concentrations of EmulGold. -
FIGS. 19 to 24 depict mean log cfu/ml of Bb12 (±SD) in orange juice with and without 3% w/v EmulGold and varying inoculation levels of Bb12. -
FIGS. 25 to 30 depict pH (±SD) of orange juice with and without 3% w/v EmulGold, inoculated with varying levels of Bb12. -
FIG. 31 depicts log cfu/ml (±SD) of Bb12 in apple juice with and without 1.3% w/v EmulGold. -
FIG. 32 depicts pH (±SD) of apple juice inoculated with Bb12 with and without 1.3% w/v EmulGold. -
FIG. 33 depicts mean log cfu/ml (±SD) of Bb12 in cranberry juice with and without 1.3% w/v EmulGold. -
FIG. 34 depicts pH (±SD) of cranberry juice inoculated with Bb12 with and without EmulGold. -
FIG. 35 depicts mean log cfu/ml (±SD) of Bb12 in orange juice, apple juice and cranberry juice. -
FIG. 36 depicts pH (±SD) of orange juice, apple juice and cranberry juice. - The probiotic composition of the present invention is prepared by dissolving gum Arabic in a carrier medium to provide a gum Arabic solution. Probiotic culture is then added to the gum Arabic solution to provide the probiotic composition.
- Gum Arabic is a highly branched arabinogalactan and is generally available in the form of a powder and requires dissolution in the carrier medium prior to addition of the probiotic culture. Gum Arabic is also available in agglomerated or already dissolved forms. Gum Arabic can be selected from either Acacia Senegal or Acacia Seyal. Both types of gum Arabic have similar properties although there are slight differences in their sugar composition and molar mass.
- The probiotic culture can either comprise harvested cells or a starter culture. The harvested cells can be prepared by routine culturing in a standard medium which can optionally be substituted with further nutrients. The cells are generally harvested by centrifugation and washed using a standard diluent such as Maximum Recovery Diluent (MRD). The cells can then be resuspended in MRD or other suitable type of diluent or medium. The gum Arabic solution is then inoculated with the cells so as to provide between 106 and 1010 cfu/ml or cfu/g of probiotic culture per ml of gum Arabic solution and preferably between 107 and 109 cfu/ml or cfu/g. In the case where the probiotic culture is a starter culture this culture is then grown in the gum Arabic solution to provide a probiotic count in this range.
- The probiotic culture could be any of Bifidobacterium animalis, Bifidobacterium adolescentis, Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium essensis, Bifidobacterium infantis, Bifidobacterium lactis, Bifidobacterium longum, Lactobacillus paracasei, Lactobacillus acidophilus, Lactobacillus delbrueckii subsp. bulgaricus, Lactobacillus casei, Lactobacillus crispatus, Lactobacillus johnsonii, Lactobacillus lactis, Lactobacillus fermentum, Lactobacillus plantarum, Lactobacillus rhamnosus, Lactobacillus reuteri, Lactobacillus salivarius, Lactobacillus amylovorus, Lactobacillus gassed, Lactobacillus pentosaceus, Enterococcus faecalis, Enterococcus faecium, Pediococcus acidilactici, Propioniobacterium freundenreichii, Saccharomyces boulardii, Streptococcus thermophilus. It has been found that gum Arabic is particularly suited to the protection of the Bifidobacterium species.
- The carrier medium used to dissolve the gum Arabic can be any type of food grade nutrient medium in the form of a liquid, aqueous based solution, semi-liquid or semi-solid which would allow dissolution of the gum Arabic. Such nutrient media include MRS broth, mMRS solution or water. Once dissolved in this carrier medium, the resultant probiotic composition can be added to any suitable type of beverage or food product thus producing a probiotic product.
- The probiotic composition has been found to be particularly useful in preparing acidic probiotic beverage and food products and in particular probiotic beverage or food products having a pH of 4 or less than 4. This has extended the type of probiotic beverage or food products and these now include fruit juices, fruit drinks, fruit juice containing products, fruit drink containing products or fruit containing products such as mixed fruit juice/dairy drinks, mixed fruit juice/non-dairy drinks, mixed fruit juice/dairy food products, mixed fruit juice/non-dairy food products, mixed fruit drink/dairy drinks, mixed fruit drink/non-dairy drinks, mixed fruit drink/dairy food products, mixed fruit drink/non-dairy food products, mixed fruit/dairy drinks, mixed fruit/non-dairy drinks, mixed fruit/dairy food products, mixed fruit/non-dairy food products.
- Alternatively, the carrier medium can itself be a beverage or food product. This beverage or food product can either be an acidic beverage or food product or can subsequently be added to an acidic beverage or food product as outlined above. If the carrier medium itself is a beverage or food product, suitable products have a pH of 4 or less than 4 and include fruit juices, fruit drinks, fruit juice containing products, fruit drink containing products or fruit containing products such as mixed fruit juice/dairy drinks, mixed fruit juice/non-dairy drinks, mixed fruit juice/dairy food products, mixed fruit juice/non-dairy food products, mixed fruit drink/dairy drinks, mixed fruit drink/non-dairy drinks, mixed fruit drink/dairy food products, mixed fruit drink/non-dairy food products, mixed fruit/dairy drinks, mixed fruit/non-dairy drinks, mixed fruit/dairy food products, mixed fruit/non-dairy food products.
- The above beverage and food products would also include products such as fruit yoghurts and fruit yoghurt drinks, fruit smoothies, and any type of berry containing beverage or food product.
- In the case where the carrier medium is a nutrient medium and the resultant probiotic composition is then added to a beverage or food product to provide a probiotic product. This product should generally have in the region of between 0.1% and 10%, and preferably between 0.5% and 5% gum Arabic by weight of the product. If the probiotic composition is being added to a beverage or food product it can generally be added at any stage during production and preferably after any heating or pasteurisation treatment.
- Alternatively, if the carrier medium is a beverage or food product, the gum Arabic can be dissolved in this beverage or food product to provide the gum Arabic solution and the probiotic culture can either be resuspended or grown in this solution.
- Optionally other components such as buffer, salts, sugars, polysaccharides, amino acids, proteins and vitamins can be added to the probiotic composition. The amounts added of each of these components would generally be as follows: buffer between 0.1% and 0.5%, salts between 10 ppm and 500 ppm, sugars between 5% and 20%, polysaccharides between 0.1% and 1%, amino acids and proteins between 0.1%-1.5% by weight of the beverage or food product and vitamins between 10-100% of the recommended daily intake (RDI) in a serving.
- An example of a buffer which could be added includes sodium citrate or citric acid. The salts added could be any of sodium salts (e.g NaCl), potassium salts (e.g. KCl), or magnesium salts (e.g. MgCl2). Examples of sugars could be dextrose, sucrose, fructose and inverted sugars. Examples of polysaccharides could be carrageenan, pectin, alginate, guar gum, carboxymethylcellulose, locust bean gum and xanthan gum. Any type of essential amino acid could be added such as isoleucine, glutamine, alanine, and cysteine. Suitable proteins would include any type of plant based or dairy based proteins, such as whey, casein, pea protein, wheat-protein and soy protein. Examples of vitamins would be Vitamin A, Thiamin (Vitamin B1), Riboflavin (Vitamin B2) and ascorbic acid (Vitamin C).
- Three probiotic compositions were prepared according to the invention, (treatments 1-3). A standard of orange juice comprising probiotic culture was also prepared, (treatment 4).
- Kerry Ingredients supplied 12×1 litre cartons of Dawn “Juicy Bits” OJ. The cartons were shipped in a silver-foil wrapped box. Three cartons appeared to have a compromised seal and were discarded. All others where stored at 4° C. The day before the expiry date of the samples, 100 ml samples of OJ were added to 100 ml screw-cap Duran glass bottles. To a number of samples 3 g of gum Arabic was added directly and all samples were held at 4° C. overnight. The following day one of two probiotic cultures were added to the samples which were then stored in temperature controlled rooms held at 4° C. or 15° C.
- Gum Arabic (GA)
- EmulGold™ powder which is made from the species Acacia senegal was supplied in a screw-cap container with a total weight of approximately 1.5 kg. Both were stored at room temperature. EmulGold™ powder was added to OJ, mixed by hand and left at room temperature for 60 min before being stored at 4° C. Similarly powder was added to mMRS prior to inoculation with the probiotic cultures. No growth was noted in the GA+mMRS solution alone after 2 days incubation under anaerobic conditions at 37° C.
- Lactobacillus paracasei NFBC 338 and Bifidobacterium animalis subsp. lactis Bb12 were both routinely cultured in Lactobacilli MRS medium (Difco, USA) supplemented with 0.05% (w/v) cysteine-hydrochloride (mMRS) and grown at 37° C. in an anaerobic work chamber (Ruskin in vivo 400, set at 8% hydrogen, 8% carbon dioxide and 84% nitrogen). Colonies of each strain were cultured on mMRS agar and were used to inoculate 10 ml mMRS broths. Each culture was incubated for 20 hours and a 1% (v/v) inoculum was used to seed a 50 ml mMRS broth that was further incubated until the culture pH fell to between pH 3.9 to 4.2, which represented a growth period of approximately 20 hours. Previously cultures of this pH were found to yield cultures with cell densities of ˜2×109 cfu/ml. Cells were harvested by centrifugation, washed in Maximum Recovery Diluent (MRD) and re-suspended in 10 ml MRD from which 1 ml was used to inoculate 100 ml OJ samples. This was estimated to yield ˜1×108 cfu of probiotic culture per ml of OJ.
- Four treatments were used, as follows;
-
Treatment 1, the probiotic cultures were grown in the presence of 3% (w/v) GA prior to their addition to the OJ samples. -
Treatment 2, probiotic cultures were re-suspended in 50 ml MRD with 30% (w/v) GA and left at room temperature for 30 min, 8 ml was added to the OJ samples. -
Treatment 3, probiotic cultures were added to OJ to which 3% (w/v) GA had been added. -
Treatment 4, probiotic cultures were added to OJ. - For each treatment, six 100 ml OJ samples were prepared with three stored at 4° C. and 15° C., respectively.
- Colony Forming Units (cfu) per ml of OJ
- The cfu/ml was determined for a 1 ml sample of OJ following serial dilution in MRD and pour plating with mMRS. Colonies were counted after 3 days incubation. Each OJ sample was tested twice and a mean cfu/ml value calculated following sampling at 0, 7, 14, 21 and 28 days for
strain - The pH of the OJ samples was determined using a Mettler Toledo pH meter calibrated prior to each series of measurements. At each time point ˜5 ml of OJ was taken and allowed to reach room temperature before a pH reading was taken.
- B. animalis subsp. lactis Bb12
- Following storage at 4° C. for 27 days there was no significant fall in strain viability in any of the OJ samples (Table 1a and
FIG. 1 ). Statistically significant differences were observed betweenTreatment 1 and the other treatments but this is likely to represent differences in the initial inoculation levels withTreatment 1 being seeded from a separate mMRS culture that contained GA. The pH values did show statistically significant differences between time points but no trend was evident, rather an up and down variation was observed. Overall, the values were considered to be relatively constant throughout the 4 week period (Table 1b andFIG. 2 ). - Following storage at 15° C. there was no significant fall in strain viability in any of the OJ samples for the first 13 days. However, at 19 days only OJ samples to which GA was added had cfu/ml values that were not significantly lower than those at day 0 (p<0.01) (Table 2a and
FIG. 3 ). At 27 days all samples showed a significant decline in cfu/ml. However, forTreatment 3, which had GA added directly as a powder, the cfu/ml counts were significantly higher than for the other treatments (Table 2b andFIG. 3 ). In Treatment 2a 2.2% w/v GA level was achieved through the addition of a concentrated solution that was premixed with the probiotic culture. InTreatment 3a 3% w/v GA concentration was attained through the addition of GA as a powder. - The pH values again showed some statistically significant differences. However, no clear trend was evident. There was a tendency for the values to be lower at the end of the trial and this may reflect the release of organic acid from non-viable cells (Table 2b and
FIG. 4 ). - L. paracasei NFBC 338
- Following storage at 4° C. for 27 days there was no significant fall in strain viability in any of the OJ samples (Table 3a and
FIG. 5 ). Indeed the statistically significant changes observed reflected a slight increase in cfu/ml during storage. This may have arisen through the disruption of cell chains and/or cell clumps which could change the cell to cfu relationship.Treatment 2 had a statistically significant higher cfu/ml at 7 days compared to the other treatments but this difference was not maintained over the next two sample points. The pH values did show statistically significant changes between time points and treatments but no trend was evident. Overall, the values were considered to be relatively constant (Table 4a andFIG. 6 ). - Following storage at 15° C. there was a significant rise in cfu/ml after 10 days which was maintained throughout the 4 week period in all of the treatments (Table 3b and
FIG. 7 ). Because of apparent cell growth the initial plating dilutions at 7 days were not sufficient to established colony counts. The pH values showed some statistically significant differences with a trend showing a fall in pH during storage (Table 4b andFIG. 8 ). This may reflect the apparent growth of the culture during storage and the subsequent release of organic acids. - This study showed that the inclusion of gum Arabic can significantly improve probiotic survival in orange juice during storage.
- Tables. Values in the same column (representing different treatments) marked A were different to those marked B with a statistically significance of p<0.01. Similarly values marked C were different to those marked D. Values in the same row (representing the same treatment at different time points) with an * had statistically significant differences at p<0.01 compared to their respective 0 day value.
-
TABLE 1a Mean log cfu/ml (± standard deviation) of orange juice inoculated with Bb12 and stored at 4° C. 0 days 6 days 13 days 20 days 27 days Treatment 1 7.82 ± 0.10 7.86 ± 0.09 7.76 ± 0.07 7.85 ± 0.11 7.74 ± 0.08 A A A A Treatment 28.00 ± 0.11 8.10 ± 0.08 7.94 ± 0.08 8.10 ± 0.08 8.09 ± 0.13 B(p = 7E−4) B(p = 4E−3) B(p = 8E−4) B(p = 2E−4) Treatment 38.03 ± 0.06 8.07 ± 0.11 8.02 ± 0.04 8.06 ± 0.03 8.03 ± 0.06 B(p = 1E−3) B(p = 9E−5) B(p = 9E−4) B(p = 3E−5) Treatment 48.04 ± 0.08 8.01 ± 0.07 7.96 ± 0.12 7.94 ± 0.25 7.96 ± 0.09 B(p = 9E−3) B(p = 7E−4) B(p = 1E−3) -
TABLE 1b pH (± standard deviation) of orange juice inoculated with Bb12 and stored at 4° C. 0 days 6 days 13 days 20 days 27 days Treatment 1 3.59 ± 0.01 3.59 ± 0.02 3.52 ± 0.06 3.56 ± 0.02 3.66 ± 0.03 B(p = 4E−3) B(p = 3E−3) Treatment 23.60 ± 0.01 3.59 ± 0.04 3.49 ± 0.04 3.57 ± 0.02 3.64 ± 0.01 B(p = 3E−3) B(p = 1E−3) Treatment 33.61 ± 0.02 3.62 ± 0.03 3.59 ± 0.06 3.64 ± 0.02 3.63 ± 0.02 A B(p = 4E−3) Treatment 43.57 ± 0.02 3.60 ± 0.02 3.50 ± 0.07 3.56 ± 0.04 3.56 ± 0.03 A -
TABLE 2a Mean log cfu/ml (± standard deviation) of orange juice inoculated with Bb12 and stored at 15° C. 0 days 6 days 13 days 19 days 27 days Treatment 1 7.82 ± 0.10 7.98 ± 0.07 7.76 ± 0.16 7.32 ± 0.13 6.01 ± 0.19 *(p = 6E−4) *(p = 6E−5) A B(p = 4E−9) C(p = 3E−3) Treatment 28.00 ± 0.11 8.07 ± 0.08 7.94 ± 0.12 7.72 ± 0.19 6.31 ± 0.04 B(p = 2E−3) *(p = 4E−9) B(p = 2E−11) D Treatment 38.03 ± 0.06 8.06 ± 0.06 7.89 ± 0.16 7.83 ± 0.19 7.55 ± 0.08 B(p = 3E−4) *(p = 5E−5) A Treatment 48.04 ± 0.08 8.04 ± 0.12 7.91 ± 0.13 7.61 ± 0.10 6.21 ± 0.13 *(p = 2E−3) *(p = 2E−3) B(p = 1E−3) B(p = 3E−8) -
TABLE 2b pH (± standard deviation) of orange juice inoculated with Bb12 and stored at 15° C. 0 days 6 days 13 days 19 days 27 days Treatment 1 3.59 ± 0.01 3.57 ± 0.01 3.51 ± 0.04 3.56 ± 0.01 3.51 ± 0.02 B(p = 2E−3) B(p = 1E−3) Treatment 23.60 ± 0.01 3.60 ± 0.03 3.50 ± 0.04 3.60 ± 0.01 3.50 ± 0.02 A C Treatment 33.61 ± 0.02 3.63 ± 0.01 3.57 ± 0.05 3.65 ± 0.01 3.48 ± 0.02 A B(p = 6E−5) *(p = 8E−3) D(p = 8E−4) Treatment 43.57 ± 0.02 3.57 ± 0.01 3.55 ± 0.05 3.60 ± 0.05 3.44 ± 0.04 B(p = 3E−3) *(p = 4E−3) -
TABLE 3a Mean log cfu/ml (± standard deviation) of orange juice inoculated with 338 and stored at 4° C. 0 days 7 days 14 days 21 days 28 days Treatment 1 7.52 ± 0.11 7.58 ± 0.04 7.64 ± 0.08 7.79 ± 0.13 7.71 ± 0.07 B(p = 1E−3) B(p = 6E−5) Treatment 27.49 ± 0.11 8.14 ± 0.28 7.56 ± 0.01 7.74 ± 0.04 7.91 ± 0.03 *(p = 7E−3) *(p = 7E−3) *(p = 1E−3) *(p = 4E−5) A A Treatment 37.33 ± 0.14 7.59 ± 0.10 7.64 ± 0.06 7.82 ± 0.10 7.66 ± 0.16 B(p = 1E−3) *(p = 2E−3) *(p = 3E−4) B(p = 0.003) Treatment 47.35 ± 0.03 7.50 ± 0.10 7.54 ± 0.14 7.79 ± 0.10 7.83 ± 0.07 B(p = 3E−4) *(p = 2E−4) *(p = 5E−5) -
TABLE 3b pH (± standard deviation) of orange juice inoculated with 338 and stored at 4° C. 0 days 7 days 14 days 21 days 28 days Treatment 1 3.62 ± 0.02 3.47 ± 0.04 3.60 ± 0.01 3.61 ± 0.01 3.70 ± 0.01 *(p = 0.003) A A *(p = 1E−3) A Treatment 23.60 ± 0.01 3.50 ± 0.03 3.61 ± 0.01 3.60 ± 0.01 3.70 ± 0.01 C *(p = 1E−4) C Treatment 33.62 ± 0.01 3.59 ± 0.05 3.56 ± 0.02 3.73 ± 0.02 3.62 ± 0.01 *(p = 6E−3) *(p = 9E−4) B(p = 2E−4) B(p = 7E−4) D(p = 2E−4) D(p = 6E−4) Treatment 43.58 ± 0.02 3.56 ± 0.04 3.52 ± 0.01 3.65 ± 0.02 3.62 ± 0.01 B(p = 1E−4)) *(p = 1E−3) B(p = 3E−4) B(p = 1E−4) D(p = 2E−4) D(p = 9E−4) -
TABLE 4a Mean log cfu/ml (± standard deviation) of orange juice inoculated with 338 and stored at 15° C. 0 days 10 days 14 days 21 days 28 days Treatment 1 7.52 ± 0.11 8.97 ± 0.15 8.71 ± 0.41 9.28 ± 0.33 9.16 ± 0.09 *(p = 2E−6) *(p = 2E−3) *(p = 5E−8) *(p = 5E−8) B(p = 4E−3) B(p = 7E−3) Treatment 2 7.49 ± 0.11 9.00 ± 0.10 9.01 ± 0.17 9.44 ± 0.30 9.02 ± 0.21 *(p = 2E−7) *(p = 2E−6) *(p = 1E−5) *(p = 8E−6) B(p = 8E−4) Treatment 3 7.33 ± 0.14 9.15 ± 0.10 8.69 ± 0.56 9.55 ± 0.32 9.15 ± 0.09 *(p = 7E−7) *(p = 5E−3) *(p = 1E−5) *(p = 6E−8) B(p = 2E−3) B(p = 9E−3) Treatment 4 7.35 ± 0.03 8.65 ± 0.15 9.04 ± 0.09 9.52 ± 0.22 9.01 ± 0.06 *(p = 2E−6) *(p = 7E−9) *(p = 7E−7) *(p = 9E−10) A A -
TABLE 4b pH (± standard deviation) of orange juice inoculated with 338 and stored at 15° C. 0 days 7 days 10 days 14 days 21 days 28 days Treatment 1 3.62 ± 0.02 3.47 ± 0.04 3.46 ± 0.02 3.40 ± 0.01 3.38 ± 0.02 3.29 ± 0.01 *(p = 2E−3) *(p = 3E−4) *(p = 2E−5) *(p = 4E−5) *(p = 4E−6) A Treatment 23.60 ± 0.01 3.50 ± 0.03 3.48 ± 0.03 3.37 ± 0.02 3.36 ± 0.01 3.28 ± 0.02 *(p = 3E−4) *(p = 1E−4) *(p = 1E−4) A Treatment 33.62 ± 0.01 3.59 ± 0.05 3.55 ± 0.04 3.36 ± 0.03 3.42 ± 0.01 3.27 ± 0.01 *(p = 6E−5) *(p = 2E−6) *(p = 1E−6) B(p = 1E−3) Treatment 43.58 ± 0.02 3.56 ± 0.04 3.48 ± 0.04 3.33 ± 0.01 3.39 ± 0.02 3.30 ± 0.01 *(p = 4E−5) *(p = 4E−4) *(p = 3E−5) B(p = 2E−4) - Kerry Ingredients supplied two batches of Dawn “Juicy Bits” OJ. All cartons were shipped in a silver-foil wrapped box and stored immediately at 4° C. on arrival.
- Kerry Ingredients supplied 3×1.89 litre plastic bottles of pasteurized White House™ Premium apple juice made from 100% pure apple juice (pressed from apples not from concentrate) and supplemented with vitamin C and calcium.
- Kerry Ingredients supplied 3×1.89 litre plastic bottles of Ocean Spray™ Cranberry Juice Cocktail containing 27% cranberry made from concentrate and juice, with added vitamin C and iron and filtered water.
- In all experiments 100 ml samples were added to 100 ml screw-cap Duran glass bottles. For selective experiments 200 ml samples were stored in 200 ml bottles for sensory analysis. Bb12 was added at specified levels the same day samples were prepared.
- EmulGold™ in the form of powder was supplied and stored at room temperature. The powder was added directly to a number of samples based on a specified w/v concentration and mixed on a shaking platform for 30 min at room temperature. In all cases, the powder was added to ˜80 ml of juice and brought up to 100 ml following complete dissolution.
- B. animatis subsp. lactis Bb12 was routinely cultured in Lactobacilli MRS medium (Difco, USA) supplemented with 0.05% (w/v) cysteine-hydrochloride (mMRS) and grown at 37° C. in an anaerobic work chamber (Ruskin in vivo 400, set at 8% hydrogen, 8% carbon dioxide and 84% nitrogen). Colonies were cultured on mMRS agar. For each batch of cells cultured prior to sample inoculation the following procedure was followed. Colonies were added to 10 ml mMRS broth and incubated for ˜24 hours. Using a 1% v/v inoculum a second broth culture was initiated and incubated for ˜20 hours or until the medium pH reached ˜4.2. A third broth culture was established using the same parameters and was found to yield ˜2×109 cfu/ml. Based on this cell density a final volume was calculated depending on the required cfu/ml of fruit juice and the number of treatments. Cells were harvested by centrifugation washed twice in sterile water and re-suspended in sterile water from which 1 ml was used to inoculate 100 ml samples. This was estimated to yield ˜2×107 cfu of probiotic per ml of sample. For other inoculation levels the culture was concentrated or further diluted to provide a constant 1 ml inoculation.
- For each treatment three 100 ml fruit juice samples were prepared.
- Colony Forming Units (cfu) per ml of OJ, AJ and CJ
- Prior to analysis each 100 ml sample was shaken by hand. Approximately 8 ml of sample was poured into a sterile universal bottle within a laminar flow hood. The cfu/ml was determined for a 1 ml sample following serial dilution in MRD and pour plating with mMRS. Colonies were counted after 2 days incubation.
- pH
- The pH of all samples was determined using a Mettler Toledo pH meter calibrated prior to each series of measurements. Following the removal of 1 ml for cfu/ml analysis samples were allowed to reach room temperature before a pH measurement was taken.
- To allow a comparison between treatments a storage index (SI) was established based on the number of days required to yield a 0.5 log reduction in cell density from that measured on the first day of sampling. In addition, the percent survival at the last day of storage was compared. This was determined by dividing the cfu/ml on the last day by the cfu/ml of the first sample ×100. By directly comparing the treatment percent survival with the respective control a fold change in survival following the inclusion of the powder was determined.
- A mean cfu/ml value and standard deviation (SD) based on triplicate analysis was established and all statistical evaluations were based on the Student's t-Test 2-tail paired for comparison between the same samples at different times and 2-tailed unpaired for comparisons between samples from different treatments. Significances were measured at a probability level p<0.05.
- All SI data is presented in Table 5. Percent survival and fold change in survival are given in Table 6.
- Using an inoculation level of 1E+08 cfu/ml for Bb12 it was shown that the strain remained stable in OJ stored at 4° C. with no decline in viability over the test period of 28 days. It was also shown, however, that with an extended storage period a gradual decline was recorded with an SI of 49 days (Table 5).
- It was further shown that the inclusion of 3% w/v EmulGold improved survival when OJ was stored at 15° C. and this was attributed to a protective mechanism which was effective when cells became stressed by the storage conditions. Similarly in this study at storage times when Bb12 viability fell in control OJ samples the inclusion of EmulGold over a range of concentrations improved survival with SI increases of between 8 and 15 days (Table 6). All treatments had a statistical significant higher cfu/ml count on the last sample day compared to the control (Table 6). Taking ΔSI, percent survival and fold increase in survival into consideration the inclusion of EmulGold at 5% w/v appeared to confer the greatest degree of protection. However, compared to the other doses only a statistical significant increase over the 1% w/v treatment was recorded.
- Interestingly, in the EmulGold containing treatments the variation between the samples, once Bb12 levels started to decline was markedly higher than those observed for the controls. The results for all viability are shown in
FIGS. 9 to 13 . - pH
- The pH values of OJ increased slightly with the addition of 3% and 5% w/v EmulGold but for 0.5% and 1% additions no differences were apparent. A possible dose effect was evident with the highest pH values (3.72-3.78) always associated with the 5% w/v concentration, which were between 0.03 and 0.06 pH units higher than the control. The relative differences between the orange juices with and without EmulGold were maintained although the absolute values did fluctuate during the course of the experiment. These changes were also seen in the control treatments and although the pH meter was calibrated before each series of measurements changes may be an artefact reflecting the accuracy over the pH range and consistency between the times measured.
- The results for pH are shown in
FIGS. 14 to 18 . - The inclusion of 3% EmulGold again resulted in a consistent increase in Bb12 survival for all samples irrespective of the starting inoculation level. The SI values increased in all cases by between 4 and 8 days, although there was no clear trend with 1E+07 being less than 1E+06 and 1E+08 (Table 5). Based on fold increase in survival all EmulGold treatments were again effective but a trend was also evident with the level of protection being inversely proportional to the level of Bb12 inoculation (Table 6).
- A marked increase in the SD for the EmulGold treatments once Bb12 viability began to fall was again observed and this affected the statistical comparisons for 1E+07 and 1E+09 treatments with probabilities greater than 0.05 despite clear differences between the final cfu/ml counts and the respective controls. At the other inoculation levels a statistical significant improvement was observed.
- The comparable control and 3% treatment in Example 2 yielded similar results. For Example 2 and 3 the control SI and percent survival were 49 and 51 days and 0.7 and 1.2%, respectively. Similarly for 3% EmulGold the SI values were 57 and 59 days, ΔSI+8 and +8, percent survival 9.8 and 11%, and fold increase in
survival 14 and 9. The results for cell stability are shown inFIGS. 19 to 24 . - pH
- The pH values associated with each treatment showed a slight but consistent increase from ˜pH 3.74 to ˜3.76 with the addition of 3% w/v Emulgold. The level of inoculation did not appear to effect pH. Again fluctuations in values during the experiment may reflect the accuracy of the pH meter, with absolute differences on a given day being maintained. Based on the common treatments from Examples 2 and 3 the reproducibility of the measurements appears to be good. However, the values were generally taken no more than 1 day apart which might explain the similar pH profiles. The results for pH are shown in
FIGS. 25 to 30 . - Bb12 viability in AJ was clearly reduced compared to OJ with a SI of 33 days and almost complete cell loss after 55 days. EmulGold produced a slight increase in SI to 36 days (Table 5). However, their protective effect was much more evident based on their overall survival values of 0.04 and 0.1%, respectively (Table 6). These represented 8000 and 20000 fold increases above the control. Again at later times the SD was higher for the powder treatments than the equivalent controls, indicating a protective mechanism operates. A better level of protection may result with the inclusion of either powder at higher concentrations. The results for cell viability are shown in
FIGS. 31 and 35 . - pH
- The pH of the apple juice samples were lower than those recorded for orange juice by an average of ˜0.1 log. The addition of EmulGold resulted in a slight increase in pH of ˜0.05 logs which was comparable to that seen for orange juice at higher powder concentrations. Again fluctuations in pH were observed over the course of the experiment but the relative difference with the control was maintained. The results for pH are shown in
FIGS. 32 and 36 . - Bb12 viability in cranberry juice was extremely poor with a SI of less than a day (Table 5). Indeed by
day 1 the cfu/ml had declined by 3 logs (Table 6). For the same inoculation level in OJ and AJ the same overall decline would have taken ˜66 and 50 days, respectively. With the inclusion of EmulGold at 1.3% w/v the SI value was 35 days. It is unclear if Emulgold protects by a similar mechanism. However, the SD did not increase during the decline of Bb12 viability and it is tempting to suggest that the mechanism of protection is different to that which operates in OJ and AJ. Red coloured juices are known to contain specific antimicrobial component, such as, polyphenols and may play a role and provide an alternative cause of cell death. This could explain why no increase was observed in the SD of EmulGold treatments compared with the control. The results for cell viability are shown inFIGS. 33 and 35 . - pH
- The pH of cranberry juice was lower than that recorded for OJ juice by ˜1.2 log units. The addition of EmulGold resulted in an increase in pH of ˜0.2 log units, which was relatively higher than the increases seen for both AJ and OJ. However, the level was still considerably lower than those for OJ or AJ. The results for pH are shown in
FIGS. 34 and 36 . - The study showed that EmulGold effectively protects Bb12 in OJ stored for over 40 days at 4° C. There was some indication that the lower inoculation levels were more effectively protected based on their fold increase in survival. Similarly there was evidence that EmulGold protected better at 5% w/v compared to lower concentrations.
- There was a consistent trend for relatively large variations between repeat samples for EmulGold treatments during the final stages of storage in orange and apple juice, which restricted statistical analysis. The resulting higher SD could indicate that once Bb12 viability begins to decline the protection is rapidly lost or that other causes of cell death take effect.
- Compared to OJ the survival of Bb12 in AJ was reduced and was extremely poor in CJ. EmulGold again provided protection although the relative level of protection was much more evident in CJ. For CJ samples a remarkable improvement in Bb12 viability was observed. Interestingly, the SD observed for protected CJ treatments, even during Bb12 decline, was comparable to those of the control treatments. This suggests that a different protective mechanism operates to that seen in OJ and AJ.
- The inclusion of the powders at 3% w/v or above increased the pH of OJ, lower concentrations increased AJ and CJ pH. The natural pH of AJ was slightly lower than that of OJ but CJ was considerably lower again. The inclusion of EmulGold resulted in a relatively higher increase in CJ pH than that seen for OJ or AJ.
- On the basis of the trials carried out it is postulated that the main cause of loss of activity of Bb12 in fruit juices is organic acid which diffuses into the cells during prolonged storage. At some point intracellular pH attains a level that cannot be reduced sufficiently once the cells are allowed to grow and this adversely affects cell viability. It has been found that gum Arabic protects the cells by reducing the rate at which acid moves into the cell. This could be achieved by either forming a barrier at the cell surface or by altering the chemistry of the organic acid. Either mechanism is eventually lost and results in a rapid increase in intracellular pH and a subsequent accelerated loss in viability when cells are cultured. Time at which protection fails has been found to be variable and because loss is also associated with accelerated cell death a relatively large variation between replicates occurs.
- In apple juice there is a higher level of organic acid which results in a shorter period of storage viability and length of protection. In cranberry juice the concentration of organic acids is further increased and results in an even higher rate of cell death than that seen in AJ controls. However, before barrier integrity is lost and the effect of acid is felt other “non-acid based antimicrobials”, such as polyphenols, build-up in the cells during storage and reduce cell viability either directly or through a reduced capacity to control intracellular pH.
-
TABLE 5 Days to attain a 0.5 log cfu/ml reduction (SI) for Bb12 stored at 4° C. in fruit juice with or without powder supplements. Approx start Juice cfu/ml SI SI (% w/v powder) ΔSI OJ 1E+08 49 59 (0.5% EmulGold) +10 OJ 1E+08 49 57 (1% EmulGold) +8 OJ 1E+08 49 57 (3% EmulGold) +8 OJ 1E+08 49 64 (5% EmulGold) +15 OJ 1E+06 54 60 (3% EmulGold) +6 OJ 1E+07 51 55 (3% EmulGold) +4 OJ 1E+08 51 59 (3% EmulGold) +8 OJ 1E+09 51 55 (3% EmulGold) +4 AJ 1E+07 33 36 (1.3% EmulGold) +3 CJ 1E+07 1 35 (1.3% EmulGold) +34 -
TABLE 6 Final reduction in Bb12 cfu/ml, percent survival and fold change in survival following storage at 4° C. in fruit juice with or without Emulgold powder supplements Expt. Approx start GLog fall % w/v GLog fall IFold Juice cfu/ml Expt (day) %G powder (day) H% change OJ 1E+08 E 2.09 (69) 0.7 A. 0.5 0.84* (69) 14.5 +21 OJ 1E+08 E B. 1 1.38* (69) 4.2 +6 OJ 1E+08 E C. 3 1.01* (69) 9.8 +14 OJ 1E+08 E D. 5 0.58* (69) 26 +37 OJ 1E+06 I 2.14 (66) 0.7 F. 3 0.88* (66) 13.2 +19 OJ 1E+07 J 2.99 (66) 0.1 G. 3 1.83 (66) 1.5 +15 OJ 1E+08 AB 1.91 (66) 1.2 AA. 3 0.96* (66) 11 +9 OJ 1E+09 K 1.85 (66) 1.8 H. 3 1.03 (66) 9.3 +5 AJ 1E+07 R 6.30 (55) 5E−06 P. 1.3 3.37* (55) 0.04 +8000 AJ 1E+07 R Q. 1.3 3.01* (55) 0.1 +20000 CJ 1E+07 U 4.54 (13) 0 S. 1.3 0.52* (14) 30 CJ 1E+07 U T. 1.3 0.31* (14) 49 GLog cfu/ml fall compared to first sample H% survival = cfu per ml at last sample point/cfu per ml first sample point × 100 IFold Change in survival = % survival in juice plus powder sample/% survival in equivalent control juice sample *Statistically significant at p < 0.05 compared to control treatment - In the specification the terms “comprise, comprises, comprised and comprising” or any variation thereof and the terms “include, includes, included and including” or any variation thereof are considered to be totally interchangeable and they should all be afforded the widest possible interpretation and vice versa.
- The invention is not limited to the embodiment hereinbefore described, but may be varied in both construction and detail within the scope of the claims.
Claims (17)
1. A probiotic composition comprising a probiotic culture having a probiotic count of between 106 and 1010 cfu/ml or cfu/g and a carrier medium;
characterised in that:
the probiotic composition further comprises between 0.1% and 99.9% gum Arabic by weight to result in a probiotic culture that is stable at a pH of 4 or less.
2. A probiotic composition as claimed in claim 1 , wherein the gum Arabic has a viscosity in the region of between 20 and 200 cP at 25% (w/w) solution and 25° C. in an aqueous solution as measured at a shear rate of between 0.1 s−1 and 1000 s−1.
3. A probiotic composition as claimed in claim 1 , wherein:
the carrier medium comprises one or more of MRS broth, mMRS solution, and water; and
the gum Arabic is in the amount of between 30% and 99% by weight.
4. A probiotic composition as claimed in claim 1 , for addition to a beverage or food product having a pH of 4 or less than 4 in an amount sufficient to provide between 0.1 and 10% gum Arabic by weight of the product.
5. A probiotic composition as claimed in claim 1 , wherein the carrier medium is a beverage or food product having a pH of 4 or less than 4 and the gum Arabic is in the amount of between 0.1 and 10% by weight.
6. A probiotic composition as claimed in claim 5 , wherein the gum Arabic is in the amount of between 0.5 and 5% by weight.
7. A probiotic composition as claimed in claim 1 , wherein the probiotic culture has a probiotic count of between 107 and 109 cfu/ml or cfu/g.
8. A probiotic composition as claimed in claim 1 , wherein the probiotic culture comprises one or more of Bifidobacterium animalis, Bifidobacterium adolescentis, Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium essensis, Bifidobacterium infantis, Bifidobacterium lactis, Bifidobacterium longum, Lactobacillus paracasei, Lactobacillus acidophilus, Lactobacillus delbrueckii subsp. bulgaricus, Lactobacillus casei, Lactobacillus crispatus, Lactobacillus johnsonii, Lactobacillus lactis, Lactobacillus fermentum, Lactobacillus plantarum, Lactobacillus rhamnosus, Lactobacillus reuteri, Lactobacillus salivarius, Lactobacillus amylovorus, Lactobacillus gasseri, Lactobacillus pentosaceus, Enterococcus faecalis, Enterococcus faecium, Pediococcus acidilactici, Propioniobacterium freundenreichii, Saccharomyces boulardii and Streptococcus thermophilus.
9. A probiotic beverage or food product comprising the probiotic composition as claimed in claim 1 .
10. A probiotic beverage or food product as claimed in claim 9 , wherein the probiotic beverage or food product comprises one or more of fruit juices, fruit drinks, fruit juice, fruit drink or fruit containing products such as mixed fruit juice/dairy drinks, mixed fruit juice/non-dairy drinks, mixed fruit juice/dairy food products, mixed fruit juice/non-dairy food products, mixed fruit drink/dairy drinks, mixed fruit drink/non-dairy drinks, mixed fruit drink/dairy food products, mixed fruit drink/non-dairy food products, mixed fruit/dairy drinks, mixed fruit/non-dairy drinks, mixed fruit/dairy food products, and mixed fruit/non-dairy food products.
11. A process for preparing a probiotic composition comprising a probiotic culture and a carrier medium, wherein the probiotic culture comprises harvested cells; and the harvested cells have a probiotic count of between 106 and 1010 cfu/ml or cfu/g, the process comprising:
dissolving between 0.1% and 99.9% gum Arabic by weight in the carrier medium to provide a gum Arabic solution; and
adding the probiotic culture to the gum Arabic solution to provide the probiotic composition.
12. (canceled)
13. (canceled)
14. A process for preparing a probiotic culture as claimed in claim 11 , wherein the carrier medium comprises one or more of MRS broth, mMRS solution, and water.
15. A process as claimed in claim 11 , wherein the probiotic composition is subsequently added to a food or beverage product having a pH of 4 or less than 4.
16. A process for preparing a probiotic culture as claimed in claim 11 , wherein the carrier medium is a beverage or food product having a pH of 4 or less than 4.
17. A composition comprising a probiotic culture and gum Arabic, the composition having a pH of 4 or less than 4.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IES2007/0683 | 2007-09-21 | ||
IE20070683 | 2007-09-21 | ||
PCT/EP2008/061829 WO2009037136A2 (en) | 2007-09-21 | 2008-09-05 | A probiotic composition |
Publications (1)
Publication Number | Publication Date |
---|---|
US20100310713A1 true US20100310713A1 (en) | 2010-12-09 |
Family
ID=40377448
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/679,171 Abandoned US20100310713A1 (en) | 2007-09-21 | 2008-09-05 | Probiotic composition |
Country Status (6)
Country | Link |
---|---|
US (1) | US20100310713A1 (en) |
EP (1) | EP2211640A2 (en) |
CA (1) | CA2699918C (en) |
IE (2) | IE20080721A1 (en) |
MX (1) | MX2010003090A (en) |
WO (1) | WO2009037136A2 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015148943A1 (en) * | 2014-03-28 | 2015-10-01 | Conjugon, Inc. | Preparation of small colony variants of therapeutic bacteria |
CN105661230A (en) * | 2016-01-20 | 2016-06-15 | 天津科技大学 | Probiotic functional beverage and probiotic food prepared from Lens culinaris by fermentation |
US20170165303A1 (en) * | 2011-06-10 | 2017-06-15 | Stephen Francis Olmstead | Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes |
KR101800174B1 (en) * | 2016-02-22 | 2017-11-22 | 롯데칠성음료주식회사 | Lactobacillus plantarum LRCC5308 strain having improved acid-resistance, method for enhancing acid-resistant stability, fruits and vegetables beverage containing the strain, and method for manufacturing thereof |
WO2019245774A1 (en) * | 2018-06-22 | 2019-12-26 | Tropicana Products, Inc. | Method of increasing probiotic viability in food products |
US11202799B2 (en) | 2012-07-09 | 2021-12-21 | Probionov | Use of thiosulfate to potentiate the anti-pathogenic effect of lactobacilli |
US11426353B2 (en) | 2020-06-24 | 2022-08-30 | 13400719 Canada Inc. | Composite coating for an active agent |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102858948B (en) * | 2010-01-08 | 2015-11-25 | 热尔韦·达诺尼公司 | There is the lactobacillus of antioxygenation |
NL2004543C2 (en) | 2010-04-13 | 2011-10-17 | Friesland Brands Bv | Probiotics-containing liquid fruit products. |
US9693578B2 (en) | 2011-01-21 | 2017-07-04 | Chr. Hansen A/S | Probiotics in fruit beverages |
ES2368401B2 (en) * | 2011-09-30 | 2013-06-27 | Universidad Miguel Hernández De Elche | PROBIOTIC OR SYMBOLIC GELIFIED PRODUCTS AND PROCEDURE FOR OBTAINING IT. |
CN108936679A (en) * | 2018-08-29 | 2018-12-07 | 广东时代食品与生命健康研究有限公司 | A kind of compound intestinal health health care product |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040005305A1 (en) * | 2000-11-14 | 2004-01-08 | Evelyn Spivey-Krobath | Nutritional composition for treating an immune condition |
US20080299255A1 (en) * | 2007-04-27 | 2008-12-04 | Naked Juice Co. Of Glendora, Inc. | Juice beverages with probiotic bacteria |
US20100272854A1 (en) * | 2006-10-02 | 2010-10-28 | Luc Terragno | Use of gum arabic for improving the growth and survival of bifidobacteria |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60314755T2 (en) * | 2003-11-20 | 2008-07-24 | Kerry Group Services International Ltd., Tralee | Low-fat dairy product |
RU2445360C2 (en) * | 2005-10-05 | 2012-03-20 | Нестек С.А. | Composition for compensation of growth retardation |
-
2008
- 2008-09-05 CA CA2699918A patent/CA2699918C/en not_active Expired - Fee Related
- 2008-09-05 IE IE20080721A patent/IE20080721A1/en not_active Application Discontinuation
- 2008-09-05 US US12/679,171 patent/US20100310713A1/en not_active Abandoned
- 2008-09-05 IE IE20080719A patent/IES20080719A2/en not_active IP Right Cessation
- 2008-09-05 WO PCT/EP2008/061829 patent/WO2009037136A2/en active Application Filing
- 2008-09-05 MX MX2010003090A patent/MX2010003090A/en active IP Right Grant
- 2008-09-05 EP EP08803798A patent/EP2211640A2/en not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040005305A1 (en) * | 2000-11-14 | 2004-01-08 | Evelyn Spivey-Krobath | Nutritional composition for treating an immune condition |
US20100272854A1 (en) * | 2006-10-02 | 2010-10-28 | Luc Terragno | Use of gum arabic for improving the growth and survival of bifidobacteria |
US20080299255A1 (en) * | 2007-04-27 | 2008-12-04 | Naked Juice Co. Of Glendora, Inc. | Juice beverages with probiotic bacteria |
Non-Patent Citations (4)
Title |
---|
Cherbut, C. et al. 2003. Acacia gum is Bifidogenic dietary fiber with high digestive tolerance in healthy humans. Microbial Ecology in Health and Disease. 15: 43-50 * |
From a texturiser to a fiber-1998. * |
Lian, W. et al. 2002. Survival of bifidobacteria after spray drying. Int. J. Fd. Micro. 74:79-86 * |
Su, P. et al. 2007. Selected prebiotics support the grwoth of probiotic mono-culture in vitro. Anaerobe, 13: 134-139. * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20170165303A1 (en) * | 2011-06-10 | 2017-06-15 | Stephen Francis Olmstead | Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes |
US11202799B2 (en) | 2012-07-09 | 2021-12-21 | Probionov | Use of thiosulfate to potentiate the anti-pathogenic effect of lactobacilli |
WO2015148943A1 (en) * | 2014-03-28 | 2015-10-01 | Conjugon, Inc. | Preparation of small colony variants of therapeutic bacteria |
AU2015237234B2 (en) * | 2014-03-28 | 2021-07-15 | Atterx Biotherapeutics, Inc. | Preparation of small colony variants of therapeutic bacteria |
CN105661230A (en) * | 2016-01-20 | 2016-06-15 | 天津科技大学 | Probiotic functional beverage and probiotic food prepared from Lens culinaris by fermentation |
KR101800174B1 (en) * | 2016-02-22 | 2017-11-22 | 롯데칠성음료주식회사 | Lactobacillus plantarum LRCC5308 strain having improved acid-resistance, method for enhancing acid-resistant stability, fruits and vegetables beverage containing the strain, and method for manufacturing thereof |
WO2019245774A1 (en) * | 2018-06-22 | 2019-12-26 | Tropicana Products, Inc. | Method of increasing probiotic viability in food products |
CN112533487A (en) * | 2018-06-22 | 2021-03-19 | 热带产品公司 | Method for increasing probiotic viability in food products |
US11426353B2 (en) | 2020-06-24 | 2022-08-30 | 13400719 Canada Inc. | Composite coating for an active agent |
Also Published As
Publication number | Publication date |
---|---|
MX2010003090A (en) | 2010-04-09 |
IES20080719A2 (en) | 2009-05-13 |
CA2699918A1 (en) | 2009-03-26 |
EP2211640A2 (en) | 2010-08-04 |
CA2699918C (en) | 2015-11-10 |
WO2009037136A3 (en) | 2009-07-16 |
IE20080721A1 (en) | 2009-04-01 |
WO2009037136A2 (en) | 2009-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2699918C (en) | A probiotic composition | |
Kneifel et al. | Microflora and acidification properties of yogurt and yogurt-related products fermented with commercially available starter cultures | |
Adhikari et al. | Viability of microencapsulated bifidobacteria in set yogurt during refrigerated storage | |
Shafiee et al. | Combined effects of dry matter content, incubation temperature and final pH of fermentation on biochemical and microbiological characteristics of probiotic fermented milk | |
Shah | Probiotic bacteria: selective enumeration and survival in dairy foods | |
US10072310B2 (en) | Process of preparing fermented milk beverage keeping high viable cell count at ambient temperature | |
EP2217083B1 (en) | Beverage compositions | |
EP2665378B1 (en) | Probiotics in fruit beverages | |
EP2547214B1 (en) | Dried fermented dairy product containing a high density of living bifidobacteria | |
KR20180105741A (en) | Probiotic juice drink | |
Randazzo et al. | Survival of Lactobacillus rhamnosus probiotic strains in peach jam during storage at different temperatures | |
PASSOS et al. | Characterization and distribution of lactic acid bacteria from traditional cocoa bean fermentations in Bahia | |
CN101262776A (en) | Fermented food products containing probiotic strains, and method for preparing same | |
CN109156686A (en) | A method of the raising fermented juice storage period probiotic active based on microencapsulation | |
JP2001112437A (en) | Production of food and drink containing bacteria of genus bifidobacterium | |
KR101800174B1 (en) | Lactobacillus plantarum LRCC5308 strain having improved acid-resistance, method for enhancing acid-resistant stability, fruits and vegetables beverage containing the strain, and method for manufacturing thereof | |
KR20200004179A (en) | Aronia fermented beverage with antioxidant function and method for manufacturing the same | |
EP1843664B1 (en) | Table olives containing probiotic microorganisms | |
Olaniyi et al. | Antimicrobial characteristics of lactic acid bacteria in African yam bean-based drink. | |
ES2250326T3 (en) | CARBON ADDITIVE FOR FOOD FERMENTATIONS AND FOOD COMPOUNDS THAT CONTAIN IT. | |
Kalantarmahdavi et al. | Viability of Lactobacillus plantarum incorporated with sourdough powder-based edible film in set yogurt and subsequent changes during post fermentation storage | |
Gallina et al. | Effect of modified chitooligosacharides on the physicochemical and microbiological characteristics of a probiotic fermented beverage | |
JP6978958B2 (en) | Method for producing fermented milk containing bifidobacteria and lactic acid bacteria | |
KR20060078894A (en) | Novel lactic acid bacteria and preparation method of fermented alcoholic beverage using the same | |
Brandão et al. | Development of probiotic cultures in a symbiotic soy beverage using different types of carbohydrate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: KERRY GROUP SERVICES INTERNATIONAL LIMITED, IRELAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:VIEBKE, CHRISTER;FLYNN, CALLAGHAN;SIGNING DATES FROM 20100318 TO 20100329;REEL/FRAME:024550/0966 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |